Medical congresses are no longer worth the investment.

About the webinar

Proposition: Medical congresses are no longer worth the investment

For: Pharma pours millions into booths, travel and sponsorships—but HCP attendance is dropping, leads are poorly captured, and post-event engagement is nearly non-existent. In the digital age, the ROI of congresses is more myth than measurable reality. Against: Congresses remain one of the few places where trust is built face-to-face, relationships are forged and deep scientific exchange happens in real time. If the right data is captured, they can offer unmatched impact for education, brand visibility and HCP engagement. For or against? Get involved, have your say!

Speakers

• Paul Simms — VP, Impatient Health
• Emma Vitalini — Head Global Digital Health Technology Innovation, Amgen
• Pierre Metrailler — CEO, Onomi
• Danie du Plessis — Chair of the Board of Directors, Medical Affairs Professional Society
• Jo Cowler — Former VP for Worldwide HCP Events & Meetings, BMS